Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $4.6 million.

  • Haemonetics' Other Working Capital Changes fell 7762.46% to $4.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $19.0 million, marking a year-over-year decrease of 6402.68%. This contributed to the annual value of $25.2 million for FY2025, which is 2588.85% down from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Other Working Capital Changes is $4.6 million, which was down 7762.46% from $5.9 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Other Working Capital Changes ranged from a high of $20.6 million in Q4 2024 and a low of -$9.3 million during Q1 2025
  • Its 5-year average for Other Working Capital Changes is $6.6 million, with a median of $5.6 million in 2023.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 122819.67% in 2024, then crashed by 15025.78% in 2025.
  • Over the past 5 years, Haemonetics' Other Working Capital Changes (Quarter) stood at $2.1 million in 2021, then soared by 39.07% to $2.9 million in 2022, then skyrocketed by 81.22% to $5.3 million in 2023, then soared by 286.69% to $20.6 million in 2024, then crashed by 77.62% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q4 2025, $5.9 million for Q3 2025, and $17.8 million during Q2 2025.